New York State Teachers Retirement System grew its holdings in shares of Globe Life Inc. (NYSE:GL - Free Report) by 6.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 97,702 shares of the company's stock after purchasing an additional 5,600 shares during the quarter. New York State Teachers Retirement System owned approximately 0.12% of Globe Life worth $12,143,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of GL. Global Assets Advisory LLC acquired a new position in Globe Life during the second quarter worth about $25,000. AdvisorNet Financial Inc lifted its stake in Globe Life by 60.0% in the 2nd quarter. AdvisorNet Financial Inc now owns 224 shares of the company's stock worth $28,000 after purchasing an additional 84 shares in the last quarter. TD Private Client Wealth LLC acquired a new position in shares of Globe Life during the 2nd quarter worth approximately $39,000. SouthState Corp acquired a new position in shares of Globe Life during the 1st quarter worth approximately $43,000. Finally, Ransom Advisory Ltd purchased a new stake in shares of Globe Life in the first quarter valued at approximately $50,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts recently commented on GL shares. Cfra Research upgraded Globe Life to a "moderate buy" rating in a research report on Friday, July 25th. Truist Financial began coverage on shares of Globe Life in a research report on Tuesday, July 15th. They set a "buy" rating and a $150.00 price target on the stock. BMO Capital Markets restated a "market perform" rating and set a $149.00 price objective (up from $114.00) on shares of Globe Life in a research report on Wednesday, July 30th. Weiss Ratings reaffirmed a "buy (b-)" rating on shares of Globe Life in a research note on Wednesday, October 8th. Finally, Morgan Stanley set a $179.00 price target on shares of Globe Life and gave the company an "overweight" rating in a research note on Tuesday, October 7th. Eight analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Globe Life presently has an average rating of "Moderate Buy" and an average target price of $152.11.
Get Our Latest Analysis on Globe Life
Globe Life Trading Up 0.9%
NYSE GL opened at $134.78 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.06 and a quick ratio of 0.06. The stock has a market capitalization of $10.92 billion, a P/E ratio of 10.77 and a beta of 0.55. The firm's 50-day moving average is $139.85 and its two-hundred day moving average is $128.95. Globe Life Inc. has a 12 month low of $100.27 and a 12 month high of $147.83.
Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $3.27 earnings per share for the quarter, beating analysts' consensus estimates of $3.25 by $0.02. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The business had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same period last year, the business earned $2.97 earnings per share. The business's revenue for the quarter was up 2.9% on a year-over-year basis. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. On average, sell-side analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 annualized dividend and a yield of 0.8%. Globe Life's dividend payout ratio is presently 8.63%.
Insider Transactions at Globe Life
In other news, CEO James Matthew Darden sold 33,270 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $135.59, for a total value of $4,511,079.30. Following the completion of the transaction, the chief executive officer owned 49,842 shares of the company's stock, valued at approximately $6,758,076.78. This trade represents a 40.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Frank M. Svoboda sold 12,500 shares of the company's stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the sale, the chief executive officer directly owned 32,747 shares in the company, valued at approximately $4,629,770.86. The trade was a 27.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 84,722 shares of company stock valued at $11,733,793. Insiders own 1.51% of the company's stock.
Globe Life Company Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Articles
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.